634 resultados para Epstein, AbrahamEpstein, AbrahamAbrahamEpstein
Resumo:
BACKGROUND Arrhythmia origin in close proximity to the phrenic nerve (PN) can hinder successful catheter ablation. We describe our approach with epicardial PN displacement in such instances. METHODS AND RESULTS PN displacement via percutaneous pericardial access was attempted in 13 patients (age 49±16 years, 9 females) with either atrial tachycardia (6 patients) or atrial fibrillation triggered from a superior vena cava focus (1 patient) adjacent to the right PN or epicardial ventricular tachycardia origin adjacent to the left PN (6 patients). An epicardially placed steerable sheath/4 mm-catheter combination (5 patients) or a vascular or an esophageal balloon (8 patients) was ultimately successful. Balloon placement was often difficult requiring manipulation via a steerable sheath. In 2 ventricular tachycardia cases, absence of PN capture was achieved only once the balloon was directly over the ablation catheter. In 3 atrial tachycardia patients, PN displacement was not possible with a balloon; however, a steerable sheath/catheter combination was ultimately successful. PN displacement allowed acute abolishment of all targeted arrhythmias. No PN injury occurred acutely or in follow up. Two patients developed acute complications (pleuro-pericardial fistula 1 and pericardial bleeding 1). Survival free of target arrhythmia was achieved in all atrial tachycardia patients; however, a nontargeted ventricular tachycardia recurred in 1 patient at a median of 13 months' follow up. CONCLUSIONS Arrhythmias originating in close proximity to the PN can be targeted successfully with PN displacement with an epicardially placed steerable sheath/catheter combination, or balloon, but this strategy can be difficult to implement. Better tools for phrenic nerve protection are desirable.
Resumo:
BACKGROUND Radiofrequency ablation (RFA) from the epicardial space for ventricular arrhythmias is limited or impossible in some cases. Reasons for epicardial ablation failure and the effect on outcome have not been systematically analyzed. METHODS AND RESULTS We assessed reasons for epicardial RFA failure relative to the anatomic target area and the type of heart disease and assessed the effect of failed epicardial RFA on outcome after ablation procedures for ventricular arrhythmias in a large single-center cohort. Epicardial access was attempted during 309 ablation procedures in 277 patients and was achieved in 291 procedures (94%). Unlimited ablation in an identified target region could be performed in 181 cases (59%), limited ablation was possible in 22 cases (7%), and epicardial ablation was deemed not feasible in 88 cases (28%). Reasons for failed or limited ablation were unsuccessful epicardial access (6%), failure to identify an epicardial target (15%), proximity to a coronary artery (13%), proximity to the phrenic nerve (6%), and complications (<1%). Epicardial RFA was impeded in the majority of cases targeting the left ventricular summit region. Acute complications occurred in 9%. The risk for acute ablation failure was 8.3× higher (4.5-15.0; P<0.001) after no or limited epicardial RFA compared with unlimited RFA, and patients with unlimited epicardial RFA had better recurrence-free survival rates (P<0.001). CONCLUSIONS Epicardial RFA for ventricular arrhythmias is often limited even when pericardial access is successful. Variability of success is dependent on the target area, and the presence of factors limiting ablation is associated with worse outcomes.
Resumo:
BACKGROUND Mapping to identify scar-related ventricular tachycardia re-entry circuits during sinus rhythm focuses on sites with abnormal electrograms or pace-mapping findings of QRS morphology and long stimulus to QRS intervals. We hypothesized that (1) these methods do not necessarily identify the same sites and (2) some electrograms are far-field potentials that can be recognized by pacing. METHODS AND RESULTS From 12 patients with coronary disease and recurrent ventricular tachycardia undergoing catheter ablation, we retrospectively analyzed electrograms and pacing at 546 separate low bipolar voltage (<1.5 mV) sites. Electrograms were characterized as showing evidence of slow conduction if late potentials (56%) or fractionated potentials (76%) were present. Neither was present at (13%) sites. Pacing from the ablation catheter captured 70% of all electrograms. Higher bipolar voltage and fractionation were independent predictors for pace capture. There was a linear correlation between the stimulus to QRS duration during pacing and the lateness of a capturing electrogram (P<0.001), but electrogram and pacing markers of slow conduction were discordant at 40% of sites. Sites with far-field potentials, defined as those that remained visible and not captured by pacing stimuli, were identified at 48% of all pacing sites, especially in areas of low bipolar voltage and late potentials. Initial radiofrequency energy application rendered 74% of targeted sites electrically unexcitable. CONCLUSIONS Far-field potentials are common in scar areas. Combining analysis of electrogram characteristics and assessment of pace capture may refine identification of substrate targets for radiofrequency ablation.
Resumo:
BACKGROUND Ventricular tachycardia (VT) refractory to antiarrhythmic drugs and standard percutaneous catheter ablation techniques portends a poor prognosis. We characterized the reasons for ablation failure and describe alternative interventional procedures in this high-risk group. METHODS AND RESULTS Sixty-seven patients with VT refractory to 4±2 antiarrhythmic drugs and 2±1 previous endocardial/epicardial catheter ablation attempts underwent transcoronary ethanol ablation, surgical epicardial window (Epi-window), or surgical cryoablation (OR-Cryo; age, 62±11 years; VT storm in 52%). Failure of endo/epicardial ablation attempts was because of VT of intramural origin (35 patients), nonendocardial origin with prohibitive epicardial access because of pericardial adhesions (16), and anatomic barriers to ablation (8). In 8 patients, VT was of nonendocardial origin with a coexisting condition also requiring cardiac surgery. Transcoronary ethanol ablation alone was attempted in 37 patients, OR-Cryo alone in 21 patients, and a combination of transcoronary ethanol ablation and OR-Cryo (5 patients), or transcoronary ethanol ablation and Epi-window (4 patients), in the remainder. Overall, alternative interventional procedures abolished ≥1 inducible VT and terminated storm in 69% and 74% of patients, respectively, although 25% of patients had at least 1 complication. By 6 months post procedures, there was a significant reduction in defibrillator shocks (from a median of 8 per month to 1; P<0.001) and antiarrhythmic drug requirement although 55% of patients had at least 1 VT recurrence, and mortality was 17%. CONCLUSIONS A collaborative strategy of alternative interventional procedures offers the possibility of achieving arrhythmia control in high-risk patients with VT that is otherwise uncontrollable with antiarrhythmic drugs and standard percutaneous catheter ablation techniques.
Resumo:
AIMS In patients presenting with spontaneous sustained ventricular tachycardia (VT) from the outflow-tract region without overt structural heart disease ablation may target premature ventricular contractions (PVCs) when VT is not inducible. We aimed to determine whether inducibility of VT affects ablation outcome. METHODS AND RESULTS Data from 54 patients (31 men; age, 52 ± 13 years) without overt structural heart disease who underwent catheter ablation for symptomatic sustained VT originating from the right- or left-ventricular outflow region, including the great vessels. A single morphology of sustained VT was inducible in 18 (33%, SM group) patients, and 11 (20%) had multiple VT morphologies (MM group). VT was not inducible in 25 (46%) patients (VTni group). After ablation, VT was inducible in none of the SM group and in two (17%) patients in the MM group. In the VTni group, ablation targeted PVCs and 12 (48%) patients had some remaining PVCs after ablation. During follow-up (21 ± 19 months), VT recurred in 46% of VTni group, 40% of MM inducible group, and 6% of the SM inducible group (P = 0.004). Analysis of PVC morphology in the VTi group further supported the limitations of targeting PVCs in this population. CONCLUSION Absence of inducible VT and multiple VT morphologies are not uncommon in patients with documented sustained outflow-tract VT without overt structural heart disease. Inducible VT is associated with better outcomes, suggesting that attempts to induce VT to guide ablation are important in this population.
Resumo:
Permanent destruction of abnormal cardiac tissue responsible for cardiac arrhythmogenesis whilst avoiding collateral tissue injury forms the cornerstone of catheter ablation therapy. As the acceptance and performance of catheter ablation increases worldwide, limitations in current technology are becoming increasingly apparent in the treatment of complex arrhythmias such as atrial fibrillation. This review will discuss the role of new technologies aimed to improve lesion formation with the ultimate goal of improving arrhythmia-free survival of patients undergoing catheter ablation of atrial arrhythmias.
Resumo:
Question: How do interactions between the physical environment and biotic properties of vegetation influence the formation of small patterned-ground features along the Arctic bioclimate gradient? Location: At 68° to 78°N: six locations along the Dalton Highway in arctic Alaska and three in Canada (Banks Island, Prince Patrick Island and Ellef Ringnes Island). Methods: We analysed floristic and structural vegetation, biomass and abiotic data (soil chemical and physical parameters, the n-factor [a soil thermal index] and spectral information [NDVI, LAI]) on 147 microhabitat releves of zonalpatterned-ground features. Using mapping, table analysis (JUICE) and ordination techniques (NMDS). Results: Table analysis using JUICE and the phi-coefficient to identify diagnostic species revealed clear groups of diagnostic plant taxa in four of the five zonal vegetation complexes. Plant communities and zonal complexes were generally well separated in the NMDS ordination. The Alaska and Canada communities were spatially separated in the ordination because of different glacial histories and location in separate floristic provinces, but there was no single controlling environmental gradient. Vegetation structure, particularly that of bryophytes and total biomass, strongly affected thermal properties of the soils. Patterned-ground complexes with the largest thermal differential between the patterned-ground features and the surrounding vegetation exhibited the clearest patterned-ground morphologies.
Resumo:
In the present paper, we report preliminary results on the 18O/16O ratios of the interstitial waters of the DSDP cores taken from subduction-related trenches near Japan: Sites 582 and 583 at the Nankai Trough off southwestern Japan, and Site 584 at the Japan Trench off northern Honshu, where thick piles of young sediments have accumulated. Special attention was paid to any differences in isotopic behavior of interstitial waters with different surrounding lithoiogy, the details of isotopic variation of interstitial waters in young, unconsolidated sediments, and the effects of sedimentary structural disturbance on interstitial waters.
Resumo:
BACKGROUND Long-term outcomes following ventricular tachycardia (VT) ablation are sparsely described. OBJECTIVES To describe long term prognosis following VT ablation in patients with no structural heart disease (no SHD), ischemic (ICM) and non-ischemic cardiomyopathy (NICM). METHODS Consecutive patients (n=695; no SHD 98, ICM 358, NICM 239 patients) ablated for sustained VT were followed for a median of 6 years. Acute procedural parameters (complete success [non-inducibility of any VT]) and outcomes after multiple procedures were reported. RESULTS Compared with patients with no SHD or NICM, ICM patients were the oldest, had more males, lowest left ventricular ejection fraction (LVEF), highest drug failures, VT storms and number of inducible VTs. Complete procedure success was highest in no SHD, compared ICM and NICM patients (79%, 56%, 60% respectively, P<0.001). At 6 years, ventricular arrhythmia (VA)-free survival was highest in no SHD (77%) than ICM (54%) and NICM (38%, P<0.001) and overall survival was lowest in ICM (48%), followed by NICM (74%) and no SHD patients (100%, P<0.001). Age, LVEF, presence of SHD, acute procedural success (non-inducibility of any VT), major complications, need for non-radiofrequency ablation modalities, and VA recurrence were independently associated with all cause mortality. CONCLUSIONS Long term follow up following VT ablation shows excellent prognosis in the absence of SHD, highest VA recurrence and transplantation in NICM and highest mortality in patients with ICM. The extremely low mortality for those without SHD suggests that VT in this population is very rarely an initial presentation of a myopathic process.
Resumo:
Back Row: Paul Schmidt, Mike Gittleson, Rick Clark, Vance Bedford, Brady Hoke, Jim Herrmann, Mike DeBord, Fred Jackson, Bobby Morrison, Stan Parrish, Erik Campbell, Terry Malone, Scot Loeffler, Jon Falk, Phil Bromley, Mike Elston
8th Row: Tim Murphy, Dave Dean, Dr. Edward Wojtys, Dr. C. Daniel Hendrickson, Danielle Tiernan, Steve Connelly, Dwight Mosely, Scott Panique, Kirk Moundros, Tad Van Pelt, Mike Sajdak, Pete Clifford, Rob Abin, Rick Brandt, Mark Ouimet, Kelly Cox, Eric Dean, Buster Stanley, Jim Schneider
7th Row: Daydrion Taylor, Todd Howard, Walter Cross, Evan Coleman, Julius Curry, Justin Fargas, Hayden Epstein, Larry Foote, Shawn Lazarus, Victor Hobson, Dave Armstrong, Deitan Dubuc, Jonathan Goodwin, John Wood, Dennis Baker, Jason Ptak, Kyle Froelich, Paul Tannous
6th Row: Aaron Richards, Cyle Young, P.J. Cwayna, Jeremy Miller, Michael Manning, Jake Malacos, Brodie Killian, Gary Rose, Rudy Smith, Joe Denay, Bennie Joppru, Dan Rumishek, Dave Petruziello, Drew Henson, Dave Terrell, Marquise Walker, Cato June
5th Row: Patrick McCall, James Whitley, William Peterson, Anthony Thomas, Ray Jackson, Bill Seymour, Shawn Thompson, Kurt Anderson, Jason Brooks, Ben Mast, Adam Adkins, Todd Mossa, Bob Fraumann, Eric Brackins, Eric Rosel, DeWayne Patmon, Anthony Jordan
4th Row: Manus Edwards, Chris Roth, Dan Williams, LeAundre Brown, Eric Wilson, Chad Carpenter, Ian Gold, Marcus Knight, Eric Warner, Maurice Williams, Jake Frysinger, Grady Brooks, Cory Sargent, Ryan Parini, Andy Sechler, Jeff Del Verne
3rd Row: Brent Washington, Kevin Bryant, Jeff Smokevich, Mark Bergin, Kenneth Jackson, Jeff Holtry, David Brandt, Steve Hutchinson, Jeff Backus, Jason Kapsner, Tommy Hendricks, Dhani Jones, Jared Chandler, Tate Schanski, Brandon Kornblue, Matt Johnson
2nd Row: Jay Feely, Darren Petterson, Jason Vinson, Noah Parker, Aaron Shea, James Hall, Steve Frazier, Chris Ziemann, Jeff Potts, Tom Brady, Josh Williams, Patrick Kratus, DiAllo Johnson, Rob Renes, Kraig Baker
Front Row: Head Coach Lloyd Carr, Marcus Ray, Andre Weathers, Nate Miller, Sam Sword, Juaquin Feazell, Mark Campbell, Jon Jansen, Jerame Tuman, Clint Copenhaver, Tai Streets, Scott Dreisbach, Chris Singletary, Clarence Williams
Resumo:
Back Row: Paul Schmidt, Mike Gittleson, Mike Elston, Teryl Austin, Brady Hoke, Jim Herrmann, Mike DeBord, Fred Jackson, Bobby Morrison, Stan Parrish, Erik Campbell, Terry Malone, Scot Loeffler, Jon Falk, Scott Draper, Phil Bromley, Jim Schneider
8th Row: Tim Murphy, Dr. Edward Wojtys, Dr. C. Daniel Hendrickson, Kevin Undeen, Mark Borgman, Brian Smalls, Michael Kaselitz, Joe Ghannam, Tommy Huff, Dave Eklund, Rick Brandt, Bob Bland, Mark Ouimet, Kelly Cox, Dennis Coyle, Zach Adami
7th Row: Jason Clyne, Brandon Williams, Greg Brooks, Shantee Orr, Jeremy LeSueur, Carl Biggs, Dave Pearson, Ronald Bellamy, Tyrece Butler, John Navarre, Andy Mignery, Andy Brown, Grant Bowman, Courtney Morgan, Phil Brabbs*, Kyle Blerlein, Chris Roth
6th Row: P.J. Cwayna, TommyJones, Tad Van Pelt, Dwight Mosley, Scott Panique, Stephen Baker, Blake Nasif, Joe Sgroi, Tony Pape, Demeterius Soloman, Norman Boebert, John Spytek, Phil Brackins, B.J. Askew, Charles Drake, Brent Cummings, Ryan Beard, Jon Shaw
5th Row: Aaron Richards, Jason Ptak, Todd Howard, Walter Cross, Julius Curry, Justin Fargas, Bennie Joppru, Dan Rumishek, Dave Petruziello, Shawn Lazarus, Victor Hobson, Dave Armstrong, Deitan Dubuc, Cato June, John Wood, Kyle Froelich, Kirk Moundros
4th Row: Mark Bergin, Cyle Young, Bob Fraumann, Kurt Anderson, Todd Mossa, Rudy Smith, Evan Coleman, Hayden Epstein, Larry Foote, Joe Denay, Drew Henson, Dave Terrell, Marquise Walker, Gary Rose, Michael Manning, Jeremy Miller
3rd Row: Matt Johnson, Ryan Parini, James Whitley, Bill Seymour, Anthony Thomas, Shawn Thompson, Adam Adkins, Jake Frysinger, Ben Mast, Eric Brackins, Eric Rosel, DeWayne Patmon, Dan Williams, Cory Sargent, Brandon Kornblue
2nd Row: Tate Schanski, Jeff Smokevitch, Kevin Bryant, Eric Wilson, Grady Brooks, David Brandt, Steve Frazier, Steve Hutchinson, Jeff Backus, Jason Kapsner, Andy Sechler, Eric Warner, Ken Jackson, Jeff Del Verne
Front Row: Chris Ziemann, Josh Williams, Tom Brady, Patrick Kratus, DiAllo Johnson, Rob Renes, Head Coach Lloyd Carr, Dhani Jones, Ian Gold, Marcus Knight, Tommy Hendricks, Aaron Shea, James Hall